|
1
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 American thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The American thyroid association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burman KD and Wartofsky L: CLINICAL
PRACTICE. Thyroid Nodules. N Engl J Med. 373:2347–2356. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernardi S, Stacul F, Michelli A, Giudici
F, Zuolo G, de Manzini N, Dobrinja C, Zanconati F and Fabris B:
12-month efficacy of a single radiofrequency ablation on
autonomously functioning thyroid nodules. Endocrine. 57:402–408.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cesareo R, Palermo A, Pasqualini V,
Simeoni C, Casini A, Pelle G, Manfrini S, Campagna G and Cianni R:
Efficacy and safety of a single radiofrequency ablation of solid
benign non-functioning thyroid nodules. Arch Endocrinol Metab.
61:173–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu W, Gong X, Zhou Q and Chen X and Chen
X: Ultrasound-guided percutaneous microwave ablation for solid
benign thyroid nodules: Comparison of MWA versus control group. Int
J Endocrinol. 2017:97240902017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yue W, Wang S, Wang B, Xu Q, Yu S, Yonglin
Z and Wang X: Ultrasound guided percutaneous microwave ablation of
benign thyroid nodules: Safety and imaging follow-up in 222
patients. Eur J Radiol. 82:e11–e16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dobnig H and Amrein K: Monopolar
radiofrequency ablation of thyroid nodules: A prospective Austrian
single-center study. Thyroid. 28:472–480. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Durante C, Costante G, Lucisano G, Bruno
R, Meringolo D, Paciaroni A, Puxeddu E, Torlontano M, Tumino S,
Attard M, et al: The natural history of benign thyroid nodules.
JAMA. 313:926–935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hay ID, Thompson GB, Grant CS, Bergstralh
EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL,
et al: Papillary thyroid carcinoma managed at the Mayo Clinic
during six decades (1940–1999): Temporal trends in initial therapy
and long-term outcome in 2444 consecutively treated patients. World
J Surg. 26:879–885. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Twomey PJ, Viljoen A, House IM, Reynolds
TM and Wierzbicki AS: Relationship between serum copper,
ceruloplasmin, and non-ceruloplasmin-bound copper in routine
clinical practice. Clin Chem. 51:1558–1559. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Habi b, M Ahsan B, Huntington T and Hasan
MA: A review on culture, production and use of Spirulina as food
for humans and feeds for domestic animals and fish. In: FAO
Fisheries and Aquaculture Circular No.1034. Food and Agriculture
Organization of the United Nations; Rome, Italy: 2008, PubMed/NCBI
|
|
12
|
Spolaore P, Joannis-Cassan C, Duran E and
Isambert A: Commercial applications of microalgae. J Biosci Bioeng.
101:87–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Becker EW: Micro-algae as a source of
protein. Biotechnol Adv. 25:207–210. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kent M, Welladsen HM, Mangott A and Li Y:
Nutritional evaluation of Australian microalgae as potential human
health supplements. PLoS One. 10:e01189852015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perrone D, Ardito F, Giannatempo G,
Dioguardi M, Troiano G, Lo Russo L, DE Lillo A, Laino L and Lo
Muzio L: Biological and therapeutic activities, and anticancer
properties of curcumin. Exp Ther Med. 10:1615–1623. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tabrizi R, Vakili S, Akbari M, Mirhosseini
N, Lankarani KB, Rahimi M, Mobini M, Jafarnejad S, Vahedpoor Z and
Asemi Z: The effects of curcumin-containing supplements on
biomarkers of inflammation and oxidative stress: A systematic
review and meta-analysis of randomized controlled trials. Phytother
Res. 33:252–262. 2019. View
Article : Google Scholar
|
|
17
|
Beghelli D, Isani G, Roncada P, Andreani
G, Bistoni O, Bertocchi M, Lupidi G and Alunno A: Antioxidant and
ex vivo immune system regulatory properties of Boswellia
serrata extracts. Oxid Med Cell Longev. 2017:74680642017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Governa P, Marchi M, Cocetta V, De Leo B,
Saunders PTK, Catanzaro D, Miraldi E, Montopoli M and Biagi M:
Effects of Boswellia Serrata Roxb. and Curcuma longa
L. in an in vitro intestinal inflammation model using immune cells
and Caco-2. Pharmaceuticals (Basel). 11:E1262018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kizhakkedath R: Clinical evaluation of a
formulation containing Curcuma longa and Boswellia
serrata extracts in the management of knee osteoarthritis. Mol
Med Rep. 8:1542–1548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schenk H, Haralambus I, Leb G, Pickel H
and Goebel R: The effect of oral contraceptives on levels of
thyroid hormone, blood coagulation and ceruloplasmin. MMW Munch Med
Wochenschr. 119:941–944. 1977.(In German). PubMed/NCBI
|
|
21
|
Schreiber V and Pribyl T: Effect of
interaction of oestrogen, testosterone and thyroid hormones on the
serum ceruloplasmin level in rats. Physiol Bohemoslov (2). 129–137.
1977.
|
|
22
|
Schreiber V, Pribyl T and Jahodová J:
Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and
the adenohypophysis to oestradiol: Inhibition by L-thyroxine.
Physiol Bohemoslov. 29:11–20. 1980.PubMed/NCBI
|
|
23
|
Dumitriu L, Bartoc R, Ursu H, Purice M and
Ionescu V: Significance of high levels of serum malonyl dialdehyde
(MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism.
Endocrinologie. 26:35–38. 1988.PubMed/NCBI
|
|
24
|
Tisato V, Gallo S, Melloni E, Celeghini C,
Passaro A, Zauli G, Secchiero P, Bergamini C, Trentini A,
Bonaccorsi G, et al: TRAIL and ceruloplasmin inverse correlation as
a representative crosstalk between inflammation and oxidative
stress. Mediators Inflamm. 2018:96295372018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Golenkina EA, Viryasova GM, Galkina SI,
Gaponova TV, Sud'ina GF and Sokolov AV: Fine regulation of
neutrophil oxidative status and apoptosis by ceruloplasmin and its
derivatives. Cells. 7:E82018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Valenzise M, Porcaro F, Zirilli G, De Luca
F, Cinquegrani M and Aversa T: Hypoceruloplasminemia: An unusual
biochemical finding in a girl with Hashimoto's thyroiditis and
severe hypothyroidism. Pediatr Med Chir. 40:2018, https://doi.org/10.4081/pmc.2018.179 View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mittag J, Behrends T, Nordström K, Anselmo
J, Vennström B and Schomburg L: Serum copper as a novel biomarker
for resistance to thyroid hormone. Biochem J. 443:103–109. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fitch CA, Song Y and Levenson CW:
Developmental regulation of hepatic ceruloplasmin mRNA and serum
activity by exogenous thyroxine and dexamethasone. Proc Soc Exp
Biol Med. 221:27–31. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kralik A, Kirchgessner M and Eder K:
Concentrations of thyroid hormones in serum and activity of hepatic
5′ monodeiodinase in copper-deficient rats. Z Ernahrungswiss.
35:288–291. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bastian TW, Lassi KC, Anderson GW and
Prohaska JR: Maternal iron supplementation attenuates the impact of
perinatal copper deficiency but does not eliminate
hypotriiodothyroninemia nor impaired sensorimotor development. J
Nutr Biochem. 22:1084–1090. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song B: Immunohistochemical demonstration
of epidermal growth factor receptor and ceruloplasmin in thyroid
diseases. Acta Pathol Jpn. 41:336–343. 1991.PubMed/NCBI
|
|
32
|
Kondi-Pafiti A, Smyrniotis V, Frangou M,
Papayanopoulou A, Englezou M and Deligeorgi H: Immunohistochemical
study of ceruloplasmin, lactoferrin and secretory component
expression in neoplastic and non-neoplastic thyroid gland diseases.
Acta Oncol. 39:753–756. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vaideeswar P, Pandit AA, Khilnani PH and
Powar HS: Differentiation of follicular adenoma and carcinoma of
thyroid by immunohistochemical demonstration of ceruloplasmin.
Indian J Pathol Microbiol. 37:165–169. 1994.PubMed/NCBI
|
|
34
|
Wang Q, Shen Y, Ye B, Hu H, Fan C, Wang T,
Zheng Y, Lv J, Ma Y and Xiang M: Gene expression differences
between thyroid carcinoma, thyroid adenoma and normal thyroid
tissue. Oncol Rep. 40:3359–3369. 2018.PubMed/NCBI
|
